Nasdaq

XCF Global (SAFX) participates in the Nasdaq Opening Bell Ceremony to mark its public listing and highlight its mission to decarbonize the aviation industry. Led by CEO Mihir Dange, XCF aims to build renewable fuel production facilities, with its New Rise Reno facility as the flagship. The ceremony will be broadcast live, showcasing XCF’s position in the sustainable aviation fuel (SAF) market. XCF is dedicated to accelerating the aviation sector’s shift to net-zero emissions through SAF development and operation.

Crown Electrokinetics (CRKN) will voluntarily delist from the Nasdaq due to non-compliance with minimum bid price requirements, following a trading suspension on March 5, 2025. The company plans to file a Form 25 with the SEC. While Nasdaq planned to file the form, CRKN opted to initiate the delisting process. The move raises questions about the company’s financial health and future trajectory, potentially leading to restructuring or alternative funding avenues. Trading may continue on the OTC market.

IDEAYA Biosciences announced stock option grants to a new employee. The company awarded 95,600 shares at $22.29 per share under its 2023 plan, aiming to attract talent. Options vest over four years, with 25% vesting after the first year. IDEAYA, a precision medicine oncology company, focuses on targeted therapies based on molecular diagnostics and synthetic lethality approaches.

Julong Holding Limited (JLHL) priced its IPO at $4.00 per share, raising approximately $5.0 million through the offering of 1,250,000 Class A ordinary shares. JLHL, trading on Nasdaq as “JLHL” from June 26, 2025, provides intelligent integrated solutions for various properties in China. US Tiger Securities, Inc. acted as the sole book-runner. The offering is expected to close on June 27, 2025.

Portage Biotech Inc. (PRTG) announced its continued listing compliance on the Nasdaq Capital Market, as confirmed by the Nasdaq. The immuno-oncology firm focuses on developing novel biologics to harness the immune system against cancer. This release contains forward-looking statements subject to risks and uncertainties, with actual results potentially differing from projections.

Lipella Pharmaceuticals Inc. is delisted from the Nasdaq Capital Market due to rule violations regarding private placement transactions. The delisting, involving the issuance of convertible preferred stock and warrants, led to the suspension of trading. While disappointed, the company is exploring alternative markets, remains focused on its clinical development plans for LP-10 and LP-310, and is pressing forward with its mission to address unmet medical needs.

LeddarTech Holdings Inc. (LDTC), an AI-powered software firm in the ADAS/AD space, will be delisted from Nasdaq on June 24, 2025. The delisting follows the company’s announcement of filing under the Bankruptcy and Insolvency Act (Canada). The company’s board of directors has resigned, and the company does not plan to appeal the decision. Further details on the BIA process will be released via Raymond Chabot Inc.’s website.

BEST SPAC I Acquisition Corp. completed its $55 million IPO, priced at $10 per unit, on Nasdaq under the symbol BSAAU. The British Virgin Islands-based SPAC’s offering, managed by Maxim Group LLC, includes an over-allotment option. With focus on the consumer goods sector, the company aims to merge with a suitable target. The SEC declared the registration statement effective on June 12, 2025.

FiEE, Inc. (MINM) will resume trading on the Nasdaq on June 2, 2025, after receiving approval. The company, previously known as Minim, is refocusing on leveraging IoT, connectivity, and AI for brand management solutions, including AI-driven content creation for KOLs and brands. CEO Rafael Li highlights the re-listing as validation and emphasizes strategic initiatives for long-term growth.

So-Young International (Nasdaq: SY) plans a reverse ADS split, changing its ADS ratio from 13:10 to 1:15, effective June 30, 2025. This adjustment, impacting ADS holders without required action, aims to proportionally increase the ADS price. Fractional entitlements will be sold, with net proceeds distributed to ADS holders. So-Young, connecting consumers with aesthetic treatments in China, highlights potential market risks.